GlaxoSmithKline: COVID-19 trials
The registry lists 10 COVID-19 studies with GlaxoSmithKline as lead sponsor. 1 are open to participants now and 8 have results posted.
Phase 1 5Phase 2 3Phase 3 1Phase 4 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in AdultsRecruitingNCT07464314Phase 1
- A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy AdultsCompletedNCT05972993Phase 1Results posted
- A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy AdultsCompletedNCT05960097Phase 2Results posted
- Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years OldCompletedNCT05477186Phase 1Results posted
- Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19CompletedNCT05305651Phase 4Results posted
- Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult ParticipantsCompletedNCT05260437Phase 1Results posted
- Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19TerminatedNCT05124210Phase 2Results posted
- A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster VaccineCompletedNCT05047770Phase 3Results posted
- Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related DiseaseCompletedNCT04376684Phase 2Results posted
- A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in AdultsCompletedNCT06680375Phase 1